Patient-Friendly Explanation

Sulphonylureas are diabetes tablets that lower blood sugar by making the pancreas release more insulin. A common side effect is weight gain, because the extra insulin encourages the body to store fat. If you take this type of tablet, your doctor can help you manage the weight gain or discuss alternative medications.

Clinical Definition

Sulphonylureas (for example gliclazide, glipizide and glimepiride) stimulate insulin secretion from pancreatic beta-cells largely independently of glucose levels, raising circulating insulin and promoting lipogenesis and fat storage. They are typically associated with 1-4 kg of weight gain and an increased risk of hypoglycaemia, in contrast with weight-neutral or weight-losing agents such as metformin and SGLT2 inhibitors. These effects should be weighed when selecting glucose-lowering therapy for people with type 2 diabetes and excess weight.

Why It Matters

Choosing diabetes medication that does not add weight matters when you are trying to lose it. NuLifeCare’s doctors can review your diabetes tablets as part of your weight management plan.